Plain-English translation of NCT06345287 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a personalized approach to treating advanced head and neck cancer that hasn't spread. After you receive initial treatment combining chemotherapy and immunotherapy, your doctors will measure how well your tumor has responded. Based on that response, you'll receive one of three different radiation therapy dose levels—all combined with more chemotherapy and ongoing immunotherapy. The goal is to find the right balance between killing cancer cells and minimizing side effects.
Current standard radiation therapy uses the same dose for all patients, but doctors don't yet know if adjusting the dose based on how individual tumors respond to initial treatment could lead to better survival and fewer complications. This trial aims to answer that question.
You likely qualify if…
You likely don't qualify if…
After your initial chemotherapy and immunotherapy, your tumor will be assessed to see how well it has responded. Based on those results, you will be assigned to one of three treatment groups, each receiving a different radiation therapy dose combined with chemotherapy and continuing immunotherapy. You will receive regular radiation treatments over several weeks, with ongoing clinic visits to monitor your response and side effects. Doctors will track your progress through imaging scans and blood tests for an extended follow-up period.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
China